AzTrials
AzTrials

Brain ConcussionNCT02754206

Cerebral Blood Flow Regulation and Concussions

An observational study of Brain Concussion and Post-Concussion Syndrome, run by Southern Methodist University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to understand how biochemical markers in blood, balance disturbances, and cognitive performance are related to brain blood flow changes after a concussion. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Brain Concussion, Post-Concussion Syndrome
How many people
79 participants
Where
1 siteUnited States
Study dates
Jan 2016to 1 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Collegiate Athletes who are currently playing a contact-collision sport.

Who may be able to join

  • Student athletes actively participating in collegiate sports. Subjects should be wiling to provide informed consent for participation in the study.

Who cannot join

  • Participants who are unable to play as a result of injury. Presence of irregular heart beat.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Southern Methodist University

    Dallas, Texas, 75205

Other trials in United States

About this study

Official title: Association Between Brain Blood Flow Regulation, Cognition, and Balance in Sports-Related Concussion

The purpose of this study is to understand how biochemical markers in blood, balance disturbances, and cognitive performance are related to brain blood flow changes after a concussion.

Read the detailed description

Comparisons will be made between control data and data following a concussion collected from athletes participating in contact-collision sports. For those suffering a concussion, comparisons will be made between day 3 (acute phase), day 21 (recovery phase), and 3 months post-concussion.

Medical subject headings
Brain Concussion, Post-Concussion Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02754206
Study groupRoleWhat they receive
ControlSubjects who are collegiate level athletes who do not have a concussion and are currently playing a contact-collision sport.
ConcussedSubjects who have recently suffered a sports-related concussion and are currently a collegiate athlete playing a contact-collision sport.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cerebral blood flow regulation

    Subject's cerebral blood flow regulation (cm/sec) at rest, during a cognitive test, and during a breathing test will be measured.

    Measured: Change in Control, 3 days post concussion, 21 days post concussion, and 3 months post concussion

Secondary outcomes (5)
  1. Blood Biomarkers

    Subjects will have their blood drawn so investigators can look at biomarkers in their blood. The biomarkers will be Tau, a-Spectrin N-Terminal Fragment, Neuron-specific enolase, Ubiquitin C-Terminal hydrolase L1, S100B, and Glial fibrillary acidic protein.

    Measured: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  2. Memory Function Test

    Subjects will be given paper tests to test their memory function.

    Measured: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  3. Balance Test

    Subjects balance will be measured using a force plate.

    Measured: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  4. Orthostatic Tolerance Test

    Subjects physiological measurements will be measured as the move from a seated position to a standing position.

    Measured: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  5. Cerebral Vasoreactivity

    Subjects will breathe normal air, a 8% carbon dioxide gas mixture, and hyperventilate.

    Measured: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2016 (estimated)
  2. Study startJan 2016
  3. Primary completion1 Sep 2021
  4. Study completion1 Sep 2021

Why it stopped: PI left university and IRB protocol closed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
79 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02754206
Sponsor's protocol ID
SouthernMethodist
Status last verified
Sep 2021
First submitted
20 Apr 2016
Last updated
14 Sep 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Purkayastha S, Adair H, Woodruff A, Ryan LJ, Williams B, James E, Bell KR. Balance Testing Following Concussion: Postural Sway versus Complexity Index. PM R. 2019 Nov;11(11):1184-1192. doi: 10.1002/pmrj.12129. Epub 2019 Apr 3.

    PubMed 30729729

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Concussion and Post-Concussion Syndrome, run by Southern Methodist University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 14 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: PI left university and IRB protocol closed). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cerebral blood flow regulation (time frame: Change in Control, 3 days post concussion, 21 days post concussion, and 3 months post concussion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02754206, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in